Hyperosinophilic syndrome in childhood: Clinical and molecular features of two cases

Pediatric Hematology and Oncology

Volumn 26, Issue 3, 2009, Pages 129-135

  Farruggia, Piero ^a,e   D'Angelo, Paolo ^a   Acquaviva, Antonio ^b   Trizzino, Antonino ^c   Tucci, Fabio ^d   Cilloni, Daniela ^d   Messa, Francesca ^b   D'Ambrosio, Alfonso ^a   Arico, Maurizio ^a  

^a G Di Cristina Children's Hospital   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e Ospedale dei Bambini G Di Cristina   (Italy)

Author keywords

BCR FGFR1; Childhood; Hypereosinophilia; Hypereosinophilic syndrome; PDGFR

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PREDNISONE; STEROID;

ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILD; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; HYPEREOSINOPHILIC SYNDROME; MALE; RARE DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; BONE MARROW EXAMINATION; CHROMOSOME ANALYSIS; TREATMENT OUTCOME;

BONE MARROW EXAMINATION; CHILD; CYTOGENETIC ANALYSIS; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; PREDNISONE; STEROIDS; TREATMENT OUTCOME;

EID: 67651151236     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010902773024     Document Type: Article

References (30)

1. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975;54:1-27.
2. Klion AD, Bochner BS, Gleich GJ, et al. and The Hypereosinophilic Syndromes Working G. Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report. J Allergy Clin Immunol. 2006;117:1292-1302.
3. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor beta to a novel etslike gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 1994;77:307-316.
4. Bain BJ. Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis. Am J Hematol. 2004;77:82-85.
5. Menssen HD, Renkl HJ, Rieder H, et al. Distinction of eosinophilic leukaemia from idiopathic hypereosinophilic syndrome by analysis of Wilms' tumour gene expression. Br J Haematol. 1998 May;101:325-334.
6. Cilloni D, Messa F, Martinelli G, et al. WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia. Leukemia. 2007;21:1442-1450.
7. Klion AD, Noel P, Akin C, et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood. 2003;101:4660-4666.
8. Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med. 1994;1330:535-538.
9. Roufosse F, Cogan E, Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med. 2003;54:169-184.
10. Alfaham MA, Ferguson SD, Sihra B, Davies J. The idiopathic hypereosinophilic syndrome. Arch Dis Child. 1987;62:601-613.
11. Spiegel R, Zalman L, Gavriel H, Horovitz Y. Hypereosinophilic syndrome in a child presenting as eosinophilic pharyngitis. J Pediatr Hematol Oncol. 2003;25:747-749.
12. Pena Segura JL, Adrados I, Jimenez Bustos JM, Cabello A, Lopez Pison J. Eosinophilic myositis in a 9 year old boy. Rev Neurol. 2001;33:960-963.
13. Sakamoto K, Erdreich-Epstein A, deClerck Y, Coates T. Prolonged clinical response to vincristine treatment in two patients with idiopathic hypereosinophilic syndrome. Am J Pediatr Hematol Oncol. 1992;14:348-351.
14. Rizzari C, Conter V, D'Angelo P, Cantu-Rajnoldi A, Masera G. Efficacy of prolonged low-dose steroid treatment in a child with idiopathic hypereosinophilic syndrome: A case report. Pediatr Hematol Oncol. 1995;12:209-212.
15. Rives S, Alcorta I, Toll T, Tuset E, Estella J, Cross NC. Idiopathic hypereosinophilic syndrome in children: Report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement. J Pediatr Hematol Oncol. 2005;27:663-665.
16. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornsen BH. NIH conference. The idiopathic hypereosinophilic syndrome: Clinical, pathophysiologic and therapeutic considerations. Ann Intern Med. 1982;97:78-92.
17. Butterfield JH. Treatment of hypereosinophilic syndromes with prednisone, hydroxyurea, and interferon. Immunol Allergy Clin North Am. 2007;27:493-518.
18. Marshall GM, White L. Effective therapy for a severe case of the idiopathic hypereosinophilic syndrome. Am J Pediatr Haematol Oncol. 1989;11:178-183.
19. Lee JH, Lee JW, Jang CS, et al. Successful cyclophosphamide therapy in recurrent eosinophilic colitis associated with hypereosinophilic syndrome. Yonsei Med J. 2002;43:267-270.
20. Butterfield JH. Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis. Acta Haematol. 2005;114:26-40.
21. Yoon TY, Ahn GB, Chang SH. Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: Report of a case and literature review. J Dermatol. 2000;27:110-115.
22. Nadarajah S, Krafchik B, Roifman C, Horgan-Bell C. Treatment of hypereosinophilic syndrome in a child using cyclosporine: Implication for a primary T-cell abnormality. Pediatrics. 1997;99:630-633.
23. Chockalingam A, Jalil A, Shadduck RK, Lister J. Allogeneic peripheral blood stem cell transplantation for hypereosinophilic syndrome with severe cardiac dysfunction. Bone Marrow Transplant. 1999;23:1093-1094.
24. Schaller JL, Burkland GA. Case report: Rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. Med Gen Med. 2001;3:9.
25. Pottier P, Planchon B, Grossi O. Complete remission with imatinib mesylate (Glivec) of an idiopathic hyper-eosinophilic syndrome associated with a cutaneous mastocytosis after failure of interferon-alpha. Rev Med Interne. 2003;24:542-546.
26. Salem Z, Zalloua PA, Chehal A, et al. Effective treatment of hypereosinophilic syndrome with imatinib mesylate. Hematol J. 2003;4:410-412.
27. Tan D, Hwang W, Ng HJ, Goh YT, Tan P. Successful treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate: A case report. Int J Hematol. 2004;80:75-7.
28. Helbig G, Stella-Holowiecka B, Majewski M, et al. A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients. Br J Hematol. 2008;141:200-204.
29. Pitini V, Teti D, Arrigo C, Righi M. Alemtuzumab therapy for refractory idiopathic hyper-eosinophilic syndrome with abnormal T cells: A case report. Br J Haematol. 2004;127:477.
30. Rothenberg ME, Klion AD, Roufosse FE, et al. Mepolizumab HES Study Group. Treatment of patients with the hypereosinophilic syndrome with Mepolizumab. N Engl J Med. 2008;358:1215-1228.